The Global Fund’s Investment Case explains the need for US$18 billion to get back on track to end AIDS, TB and malaria, accelerate progress toward the Sustainable Development Goal (SDG) 3 of “health and well-being for all” and universal health coverage, and strengthen pandemic preparedness.
In the 20 years since the Global Fund was created, the partnership has saved 44 million lives and cut the death toll from the three diseases by 40%. But the Global Fund’s Results Report revealed significant progress has been lost because of the COVID-19 pandemic and global resource needs have increased. This is why the Global Fund funding needs are higher than in 2019 for the Sixth Replenishment.
“In the face of the catastrophic impact of COVID-19 on the fight against HIV, TB and malaria, the choice is stark: We either increase funding, or we abandon hope of finally defeating these epidemics by 2030,” said Peter Sands, Executive Director of the Global Fund. “We must increase support to countries to build more resilient, sustainable and inclusive systems for health. This is crucial for ending HIV, TB and malaria, defeating COVID-19 and protecting people from future infectious disease threats around the world.”
A successful Replenishment would allow the partnership to:
- Save 20 million lives between 2024 and 2026, reducing the mortality rate by 64% across the three diseases by 2026, relative to 2020 levels.
- Avert more than 450 million infections or cases, reducing the incidence rate by 58% across the three diseases by 2026, relative to 2020 levels.
- Reduce the death toll across the three diseases to 950,000 in 2026, down from 2.4 million in 2020, and from 4 million in 2005.
- Catalyze the scale-up of domestic investments of up to US$59 billion toward ending the three diseases and strengthening systems for health through co-financing requirements and technical assistance on health financing.
- Reinforce systems for health and pandemic preparedness by investing approximately US$6 billion to support health care workers; strengthen laboratories, diagnostic tools, supply chain management, information and financial systems; tackle antimicrobial resistance, including drug-resistant TB; reinforce community systems; and accelerate the shift toward patient-centered, differentiated models of care.
- Yield a return on investment of 1:31 with every dollar invested in fighting the three diseases resulting in US$31 in health gains and economic returns, further contributing to the achievement of the overall SDG agenda.
“When the Global Fund was created 20 years ago, HIV, TB and malaria seemed unbeatable,” said Lady Roslyn Morauta, Vice-Chair of the Global Fund Board. “But we have proven that with science, adequate resources and effective global and local collaboration, we can force even the deadliest diseases into retreat. Ahead of the Global Fund’s Seventh Replenishment, and less than a decade to the United Nations Sustainable Development Goals, we call the entire partnership to mobilize to increase financial resources to fight and defeat the three diseases”.
